In October 2020, the U.S. Food and Drug Administration (FDA) required the drug label to be updated for all nonsteroidal anti-inflammatory medications to describe the risk of kidney problems in unborn babies that result in low amniotic fluid. They recommend avoiding NSAIDs in pregnant women at 20 weeks or later in pregnancy.
Fenoprofen
Indoprofen
Ketoprofen
Loxoprofen
Aceclofenac
Ibuprofen
Diclofenac
Naproxen